HomeCompareHMACW vs JNJ

HMACW vs JNJ: Dividend Comparison 2026

HMACW yields 2222.22% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HMACW wins by $26607504688.24M in total portfolio value
10 years
HMACW
HMACW
● Live price
2222.22%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26607504688.26M
Annual income
$24,443,703,761,807,280.00
Full HMACW calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HMACW vs JNJ

📍 HMACW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHMACWJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HMACW + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HMACW pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HMACW
Annual income on $10K today (after 15% tax)
$188,888.89/yr
After 10yr DRIP, annual income (after tax)
$20,777,148,197,536,188.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, HMACW beats the other by $20,777,148,197,535,484.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HMACW + JNJ for your $10,000?

HMACW: 50%JNJ: 50%
100% JNJ50/50100% HMACW
Portfolio after 10yr
$13303752344.14M
Annual income
$12,221,851,880,904,054.00/yr
Blended yield
91.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HMACW
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HMACW buys
0
JNJ buys
0
No recent congressional trades found for HMACW or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHMACWJNJ
Forward yield2222.22%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26607504688.26M$20.0K
Annual income after 10y$24,443,703,761,807,280.00$827.78
Total dividends collected$26455115546.17M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HMACW vs JNJ ($10,000, DRIP)

YearHMACW PortfolioHMACW Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$232,922$222,222.22$10,676$355.77+$222.2KHMACW
2$5,086,656$4,837,429.33$11,407$389.39+$5.08MHMACW
3$104,173,443$98,730,720.93$12,198$426.53+$104.16MHMACW
4$2,001,166,924$1,889,701,340.37$13,056$467.62+$2001.15MHMACW
5$36,067,485,611$33,926,237,001.88$13,987$513.12+$36067.47MHMACW
6$610,050,404,477$571,458,194,873.63$14,998$563.56+$610050.39MHMACW
7$9,686,139,336,337$9,033,385,403,546.24$16,098$619.52+$9686139.32MHMACW
8$144,409,519,569,037$134,045,350,479,156.38$17,295$681.69+$144409519.55MHMACW
9$2,022,243,856,495,371$1,867,725,670,556,501.50$18,599$750.82+$2022243856.48MHMACW
10$26,607,504,688,257,330$24,443,703,761,807,280.00$20,022$827.78+$26607504688.24MHMACW

HMACW vs JNJ: Complete Analysis 2026

HMACWStock

Hainan Manaslu Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. The company was founded in 2021 and is based in Haikou, China.

Full HMACW Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HMACW vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HMACW vs SCHDHMACW vs JEPIHMACW vs OHMACW vs KOHMACW vs MAINHMACW vs ABBVHMACW vs MRKHMACW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.